Accepted Manuscript Isolation and characterization of a Bacillus atrophaeus strain and its potential use in food preservation Yaoqi Guo, En Huang, Xu Yang, Liwen Zhang, Ahmed E. Yousef, Jin Zhong PII:
S0956-7135(15)30164-X
DOI:
10.1016/j.foodcont.2015.08.029
Reference:
JFCO 4619
To appear in:
Food Control
Received Date: 3 April 2015 Revised Date:
14 August 2015
Accepted Date: 25 August 2015
Please cite this article as: Guo Y., Huang E., Yang X., Zhang L., Yousef A.E. & Zhong J., Isolation and characterization of a Bacillus atrophaeus strain and its potential use in food preservation, Food Control (2015), doi: 10.1016/j.foodcont.2015.08.029. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
Isolation and Characterization of a Bacillus atrophaeus Strain and Its Potential Use in
RI PT
Food Preservation
SC
Yaoqi Guoa, b*, En Huangb*, Xu Yangb, Liwen Zhangd, Ahmed E. Yousefb, c, Jin Zhonga a
TE D
M AN U
State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, PR China b Department of Food Science and Technology, The Ohio State University, OH 43210, USA c Department of Microbiology, The Ohio State University, OH 43210, USA d Mass Spectrometry and Proteomics Facility, The Ohio State University, Columbus, OH 43210, USA
EP
Running title: Bacillus atrophaeus strain and potential use in food preservation
AC C
Keywords: Bacillus atrophaeus; antimicrobials; subtilosin; food preservation.
*Authors contributed equally to this work. Correspondences: Jin Zhong, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, PR China. Tel/Fax: +86 10 64807401. E-mail:
[email protected]. Ahmed E. Yousef, Department of Food Science and Technology, The Ohio State University, OH 43210, USA. E-mail:
[email protected].
1
ACCEPTED MANUSCRIPT Abstract
2
Microorganisms are widely distributed in food and contribute to food safety due to
3
production of antagonistic substances. A new bacterial strain, OSY-7LA, was isolated from a
4
Chinese delicacy food and exhibited strong antagonistic activity against Listeria innocua. It
5
was identified as Bacillus atrophaeus by morphological, physiological, and biochemical
6
properties and genetic relatedness. The culture supernatant has antimicrobial activities against
7
the Gram-positive pathogens tested, namely, L. monocytogenes, B. cereus and
8
methicillin-resistant Staphylococcus aureus. The antimicrobial agents were harvested by
9
solvent extraction and were purified by high performance liquid chromatography (HPLC).
10
Matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS) and tandem
11
mass spectrometry (MS/MS) were performed to identify these compounds. A protonated ion
12
at m/z 3401.414 corresponded to the molecular mass of subtilosin, and the identity of the
13
antimicrobial agent was confirmed by amplification of subtilosin gene (sbo) from isolate’s
14
genomic DNA. Sodiated ions at m/z 1030.553, 1044.642 and 1058.701 were identified as
15
C13, C14 and C15 surfactins. LC/MS analysis proved the production of plipastatin by
16
OSY-7LA. Supplement of crude extract of OSY-7LA supernatant in Vienna sausage that was
17
inoculated with L. innocua showed 2-log reduction after 12 and 24 h. The new strain and
18
related antimicrobials are potentially useful in food preservation.
AC C
EP
TE D
M AN U
SC
RI PT
1
19
20 2
ACCEPTED MANUSCRIPT 21
1. Introduction Foodborne pathogens have posed serious health challenges to human and led to big
23
economic losses in food production and storage. Preservatives are commonly used to combat
24
these pathogens and prevent food spoilage. Since the demand for chemical free food is
25
increasing, alternatives to chemical preservatives are needed. Ideally, the alternatives are
26
isolated from natural sources and are well-suited for food applications. Bacteriocins are
27
ribosomally synthesized antimicrobial peptides or proteins from bacteria (Jack, Tagg, & Ray,
28
1995). Bacteriocins have relatively narrow spectrum and are good candidates as food
29
preservatives, shelf life-extenders and ingredients (Galvez, Abriouel, Lopez, & Ben Omar,
30
2007). The feasibility of applying bacteriocins in food has been widely evaluated. Lacticin
31
3147 has been used to control nonstarter lactic acid bacteria in cheese, and to inhibit Listeria
32
strains and Bacillus cereus in different foods (Guinane, Cotter, Hill, & Ross, 2005). Pediocin
33
PA-1/AcH significantly reduced the number of Listeria monocytogenes on meat surface when
34
it was incorporated into a biocomposite packaging film (Woraprayote, et al., 2013). The
35
enterocin AS-48 producing strain inhibited growth of B. cereus, but had no effect on the
36
starter when it was inoculated in the milk for cheese production (Galvez, et al., 2007).
37
However, nisin is the only commercially available bacteriocin for food applications (Perez,
38
Zendo, & Sonomoto, 2014). Nisin is produced by Lactococcus lactis and the bacteriocin has
39
been applied in food in more than fifty countries (Reunanen & Saris, 2003). It was reported to
40
decrease the number of L. monocytogenes in cottage cheese and has been showed to be
41
effective in many foods such as milk, fish and meat products (Ross, Morgan, & Hill, 2002).
AC C
EP
TE D
M AN U
SC
RI PT
22
3
ACCEPTED MANUSCRIPT Nevertheless, resistance of pathogens (e.g., L. monocytogenes) to nisin has been reported
43
(Crandall & Montville, 1998). Lack of efficacy of nisin against Gram-negative bacteria and
44
low efficacy at neutral pH are some of the drawbacks that are limiting the application of nisin
45
in food (He, et al., 2007).
RI PT
42
Subtilosin represents a new kind of lantibiotic due to the unique thioether bond formation
47
between Cys and Phe (Kawulka, et al., 2004). It exhibited good antimicrobial activity against
48
L. monocytogenes, when used alone or in combination with curcumin (Amrouche, Sutyak
49
Noll, Wang, Huang, & Chikindas, 2010). Shelburne et al. (2007) found that subtilosin was
50
effective against both Gram-positive and Gram-negative bacteria,and it was active in a wide
51
pH range from 2 to 10 (Sutyak, Wirawan, Aroutcheva, & Chikindas, 2008). These findings
52
suggest that subtilosin is potentially a good substitute of nisin as food preservative. However,
53
the application of subtilosin in food has not been reported.
TE D
M AN U
SC
46
The aim of this study was to screen food samples for bacterial strains and bacterioins
55
with promising antimicrobial properties. A bacterial strain, designated as OSY-7LA, was
56
isolated and found to produce the lantibiotic subtilosin. Production, purification and
57
identification of subtilosin and its application in Vienna sausage were described.
58
2. Materials and Methods
59
2.1 Strain Screening
AC C
EP
54
60
Food samples, including different kind of cheeses and vegetables, were purchased from
61
local food stores (Columbus, OH) and were screened for isolates with antimicrobial activity. 4
ACCEPTED MANUSCRIPT The screening procedure of He et al. (2007) was used with modifications. Briefly, samples
63
were suspended in 0.1% peptone water and homogenized by a stomacher or a blender. The
64
homogenates were serially diluted and passed through hydrophobic grid membranes with
65
pore size of 0.45 µm (ISO-GRID; Neogen Corporation, Lansing, MI). The membranes were
66
then placed onto tryptose agar and incubated at 30 °C for 48 h. The membranes carrying
67
bacterial colonies were removed and saved, but the agar plates were overlaid with soft agar
68
seeded with L. innocua ATCC 33090 or Escherichia coli K-12. The seeded agar plates were
69
incubated at 37 °C overnight and inspected for signs of antimicrobial activity. Colonies on
70
the membrane that produced inhibitory zones were transferred and streaked onto new tryptose
71
agar plates. A sample of “Facai”, a Chinese delicacy food (Gao, 1998), yielded a strain with
72
potent antimicrobial activity against L. innocua and was given OSY-7LA designation.
73
2.2 Cultures and media
TE D
M AN U
SC
RI PT
62
Tryptose agar was used to propagate the new isolate OSY-7LA. Indicator organisms and
75
media used in this study are listed in Table 1. A stock of the new isolate was prepared by
76
inoculation in tryptic soy broth and overnight incubation at 30 °C; incubated culture was
77
mixed with sterile glycerol (final concentration 20%), and stored at -80 °C.
78
2.3 Phenotypic examination
AC C
EP
74
79
Gram staining, spore staining and scanning electron microscopy were employed to
80
examine the morphological properties of OSY-7LA. Sample preparation for scanning
81
electron microscopy was done as described previously (Kaletunc, Lee, Alpas, & Bozoglu, 5
ACCEPTED MANUSCRIPT 2004) with modifications. Briefly, the isolate OSY-7LA was grown on tryptose agar at 30 °C
83
for three days. A single colony was suspended in phosphate buffer (0.05 mol/l, pH 7.0) and
84
washed three times by centrifugation and resuspension in the same buffer. Cells were fixed in
85
fixative (2.5% glutaraldehyde in 0.1 mol/l phosphate buffer with 0.1 mol/l sucrose, pH 7.4) at
86
4 °C for ~12 hours and resuspended in phosphate buffer (0.05 mol/l, pH 7.0). The cell
87
suspension was passed through a 0.22 µm membrane (Millipore Corp., Bedford, MA), and
88
bacteria on the membrane were dehydrated using an ascending series of ethanol solutions.
89
After dehydration by ethanol solutions, bacterial cells were chemically dried using an
90
ascending series of hexamethyldisilazane (HMDS) in ethanol and the residual HMDS
91
solution was evaporated. The bacteria were coated with a thin layer of gold-palladium in a
92
Cressington 108 Sputter Coater (Ted Pella Inc., Redding, CA) and examined by a scanning
93
electron microscope (SEM; NOVA NanoSEM 400, FEI, Hillsboro, OR) with accelerating
94
voltage at 5 kV. The SEM observations were performed at The Ohio State University
95
Campus Microscopy and Imaging Facility.
96
2.4 Biochemical tests
AC C
EP
TE D
M AN U
SC
RI PT
82
97
A commercial biochemical test kit (API 50 CH strips and CHB medium, BioMerieux,
98
Inc., Durham, NC) was used to characterize the carbohydrates fermentation pattern of the
99
new isolate. The biochemical tests included catalase, nitrate reduction, formation of indole,
100
deamination of phenylalanine, utilization of citrate and hydrolysis of starch and casein. The
101
wells containing substrates were inoculated with the new isolate at appropriate density and
6
ACCEPTED MANUSCRIPT were incubated at 30 °C for 24-48 h. Results were recorded and identification was done by
103
referring to the database provided by the manufacturer.
104
2.5 Genetic relatedness by sequencing 16S rDNA
RI PT
102
Genomic DNA of the new isolate was extracted using a commercial kit (DNeasy Blood
106
& Tissue, QIAGEN, Valencia, CA). Universal primers specific for bacterial 16S rDNA were
107
used in the polymerase chain reaction, PCR (Weisburg, Barns, Pelletier, & Lane, 1991). The
108
PCR included incubation at 94 °C for 3 min, followed by 30 cycles, each including 1 min at
109
94 °C, 1 min at 52 °C, and 2 min at 72 °C. The final extension was performed at 72 °C for 10
110
min. The amplified 16S rDNA was purified using a commercial DNA extraction kit (QIA
111
quick gel extraction kit, QIAGEN). The amplified DNA was sequenced by an automated
112
DNA analyzer (Applied Biosystems, Foster City, CA) at the Plant-Microbe Genomics
113
Facility, The Ohio State University. The derived DNA sequence was compared to known
114
bacteria in the National Center for Biotechnology Information database (NCBI Genebank)
115
using Basic Local Alignment Search Tool (BLAST) algorithm.
116
2.6 Isolation and purification of antimicrobial agents
AC C
EP
TE D
M AN U
SC
105
117
Strain OSY-7LA was inoculated in 500 ml tryptic soy broth in a two liter baffled flask
118
with a cotton plug and incubated in a rotary shaker (New Brunswick Scientific, Edison, NJ)
119
at 30 °C for 36 h with agitation at 200 rpm. Cells were removed by centrifugation at 7,700×g
120
for 15 min. The supernatant was mixed with 125 ml n-butanol and agitated for one hour
121
(Huang, et al., 2009; McCormick, et al., 1998). Subsequently, the organic solvent phase was 7
ACCEPTED MANUSCRIPT collected and the solvent was removed at 40 °C, under vacuum, using a rotary evaporator.
123
The generated powder was dissolved in 5 ml Tris-Cl buffer (0.02 mol/l, pH 7.0) followed by
124
centrifugation and filtration (0.22 µm, Millipore). Resultant filtrate (crude extract) was
125
applied to high-performance liquid chromatography (HPLC) system (Hewlett Packard 1050,
126
Agilent Technologies, Palo Alto, CA) for further purification. The purification was done
127
using a reverse phase column (Alltima C18, 250×10 mm, particles 5 µ, Alltech Associates,
128
Inc., Deerfield, IL) and the mobile phase consisted of (A) acetonitrile with 0.1%
129
trifluoroacetic acid (TFA) and (B) HPLC-grade water containing 0.1% TFA. For each run,
130
100 µl of crude extract was loaded to the column and separated by a linear gradient of 0 to
131
100% acetonitrile over 30 min at the flow rate of 1.5 ml/min. UV-detectorwas set at 220 nm
132
to monitor eluted compounds. Fractions from multiple runs were combined, lyophilized and
133
dissolved in Tris-Cl buffer (0.02 mol/l, pH 7.0) for antimicrobial activity assay. The fractions
134
exhibiting antimicrobial activity were stored at 4 °C until further analyses.
135
2.7 Antimicrobial activity determination and inhibition spectrum
EP
TE D
M AN U
SC
RI PT
122
The spot-on-lawn method (Fujita, et al., 2007) was used to determine the inhibitory
137
spectrum of culture supernatant, whereas the microplate assay method (Floriano, Ruiz-Barba,
138
& Jimenez-Diaz, 1998) was used to determine the antimicrobial activity of purified
139
antimicrobial agents. For the spot-on-lawn method, 10 µl of each indicator culture (109
140
CFU/ml) was seeded in 10 ml soft agar and was poured onto basal tryptose agar. Culture
141
supernatants (10 µl, each), which presumably contain antimicrobial agents, were then spotted
142
onto these indicator lawns. Inoculated plates were incubated at 37 °C overnight to manifest
AC C
136
8
ACCEPTED MANUSCRIPT any antimicrobial activity. For antifungal test, Rhizopus arrhizus was inoculated in the centre
144
of antibiotic-containing plate count agar (APCA; Table 1) and held at 25 °C for 48 h. Culture
145
supernatant (10 µl) was spotted at the edge of the fungal mycelium and the plate was held at
146
25 °C for one day before the antifungal activity was observed. For microplate assay, L.
147
innocua was diluted to 106 CFU/ml and an aliquot of 100 µl was dispensed into each well of
148
the microplate. Purified antimicrobial agents were then added into the wells to a final volume
149
of 200 µl, whereas distilled water was used as negative control. The microplate was
150
incubated at 37 °C for 8 h and cell density was recorded by a spectrophotometric microplate
151
reader (Vmax Kinetic Microplate Reader, Molecular Devices Corp., Menlo Park, CA) at
152
wavelength of 600 nm. Fractions producing lower cell density, compared to negative control,
153
were considered inhibitory. The activity was presented in arbitrary unit per millilitre (AU/ml)
154
which is the reciprocal of the highest dilution exhibiting antimicrobial activity corresponding
155
to 1 ml of non-diluted supernatant.
156
2.8 Amplification of subtilosin gene
EP
TE D
M AN U
SC
RI PT
143
A single colony of OSY-7LA was inoculated in 10 ml tryptic soy broth supplemented
158
with 0.6% yeast extract (TSBYE) and incubated overnight at 30 °C. Cells were harvested by
159
centrifugation of 1.5 ml culture at 16,100×g for 5 min. Genomic DNA was extracted using a
160
commercial kit (DNeasy Blood & Tissue kit, QIAGEN). Polymerase chain reaction was
161
performed to amplify the subtilosin gene from genomic DNA using two primers as described
162
previously (Zheng, Yan, Vederas, & Zuber, 1999). Amplification was conducted as follows:
163
(A) an initial incubation for 3 min at 94°C; (B) 30 cycles of denaturation (1 min at 94 °C),
AC C
157
9
ACCEPTED MANUSCRIPT annealing (1 min at 55 °C) and elongation (2 min at 72 °C); (C) final extension at 72 °C for
165
10 min. Resulting products were purified using a commercial DNA extraction kit (QIA quick
166
gel extraction kit, QIAGEN). The amplified DNA was sequenced by an automated DNA
167
analyzer (Applied Biosystems) at the Plant-Microbe Genomics Facility, The Ohio State
168
University.
169
2.9 MALDI-TOF, Quadrupole-time of flight MS/MS and LC/MS/MS analyses
SC
RI PT
164
Fractions purified from HPLC were subjected to MALDI-TOF and Quadrupole-time of
171
flight MS/MS analyses. LC/MS/MS was employed for investigation of known antifungal
172
agent in culture supernatant since OSY-7LA showed antifungal activity. Details of these tests
173
were described elsewhere (Guo, Huang, Yuan, Zhang, & Yousef, 2012).
174
2.10 Inhibition of Listeria innocua in Vienna sausage
TE D
M AN U
170
A piece of sterile Vienna sausage (~ 15 g) was placed in a sterile stomacher bag. An
176
aliquot of 0.5 ml diluted (500 times) overnight L. innocua culture was inoculated onto the
177
surface of the sausage. Crude extract of OSY-7LA was inoculated at a final concentration of
178
125 AU/sausage (~30 µl) on the same sausage samples. The samples were then mixed and
179
incubated at room temperature (25 °C). Samples were taken at 1, 12 and 24 h for enumeration
180
and results were compared between the crude extract group and control group.
181
3. Results
182
3.1 Strain Identification
AC C
EP
175
10
ACCEPTED MANUSCRIPT Several hundred isolates were screened for antimicrobial activity against L. innocua
184
ATCC 33090 and E. coli K-12. A strain displaying potent antimicrobial activity against L.
185
innocua was isolated from “Facai” and was given OSY-7LA designation. The isolate formed
186
yellow colonies on tryptose agar and produced black pigments after several days of
187
incubation. The bacterium exhibited aerobic behaviour in broth culture and formed central
188
endospores. The new strain is a rod-shaped, 0.5 by 2.3 µm (Fig. 1), Gram-positive and spore
189
forming bacterium. It is positive for catalase, hydrolysis of casein and starch, utilization of
190
citrate and nitrate reduction, and negative for indole production and decomposition of
191
phenylalanine. Analysis of 16S rRNA gene showed a 99% similarity of OSY-7LA with B.
192
atrophaeus, B. subtilis and B. amyloliquefaciens.. According to the biochemical test kit (API
193
strips) results, the new isolate exhibited 99.7% similarity with B. subtilis and B.
194
amyloliquefaciens; however, B. atrophaeus is not in the reference database provided by
195
manufacturer. When propagated on tryptose agar, a nearly glucose-free medium, production
196
of black pigment is the unique characteristic of B. atrophaeus within the Bacillus species
197
(Nakamura, 1989). Therefore, the new isolate was assigned as B. atrophaeus.
198
3.2 Antimicrobial spectrum
AC C
EP
TE D
M AN U
SC
RI PT
183
199
Culture supernatant of B. atrophaeus OSY-7LA showed antimicrobial activities against
200
all Gram-positive bacteria tested; these are L. monocytogenes, L. innocua, B. cereus,
201
methicillin-resistant S. aureus and Enterococcus faecalis (Table 1). No activity was observed
202
against the tested Gram-negative bacteria, E. coli, Yesinia enterocolitica and Salmonella
11
ACCEPTED MANUSCRIPT Typhimurium. A fungus, Rhizopus arrhizus, was also tested and was found susceptible to
204
OSY-7LA culture supernatant.
205
3.3 Purification and identification of antimicrobial agents
RI PT
203
Culture supernatant of the new isolate showed distinct antimicrobial activity against L.
207
innocua, but no activity against E. coli K-12; therefore, the former was used as an indicator
208
during purification of the antimicrobial agent. After separation through HPLC, four fractions
209
exhibited antimicrobial activity against L. innocua (Fig. 2). Fraction 1 showed strong
210
antagonistic activity whereas other three fractions exhibited weak activity. All four fractions
211
were subjected to mass spectrometry analyses. Fraction 1, with retention time of 23.06 min,
212
gave a protonated ion at m/z 3401.414 (Fig. 3a), which matched the molecular weight of
213
subtilosin (Stein, Dusterhus, Stroh, & Entian, 2004). The intact and tryptic-digested
214
compounds were then analysed by tandem MS. However, both of these analyses failed to
215
elucidate the structural information, suggesting that the compound probably contained
216
inter-residual linkage. Polymerase chain reaction was subsequently conducted to confirm the
217
presence of subtilosin gene in OSY-7LA genomic DNA. A fragment of 1.2 kb, stretching 512
218
bp upstream and 578 bp downstream of subtilosin gene (Zheng, et al., 1999), was
219
successfully amplified and sequenced. Translated amino acid sequence was identical to
220
subtilosin which verifies that the compound in HPLC fraction 1 was subtilosin.
AC C
EP
TE D
M AN U
SC
206
221
HPLC fractions 2, 3 and 4, at the retention times of 29.04, 30.16 and 31.35 min, showed
222
ions at m/z 1030.553, 1044.642 and 1058.701, respectively (Fig. 3b, c, d). These ions are
223
consistent with the sodiated surfactin homologues (Pecci, Rivardo, Martinotti, & Allegrone, 12
ACCEPTED MANUSCRIPT 2010) and were further analyzed by tandem MS. The molecular ion at m/z 1030.553 resulted
225
in two sets of product ions: 917.56, 804.47, 689.46, 590.38 and 707.48, 594.34, 481.27,
226
382.20, 267.17 (Fig. 4). The first series suggested losing of Leu, Leu-Leu, Leu-Leu-Asp and
227
Leu-Leu-Asp-Val from the parent ion. The second series indicated fragments losing fatty acid
228
(FA)
229
FA-Glu-Leu-Leu-Val and FA-Glu-Leu-Leu-Val-Asp, respectively). This information is
230
consistent with C13 surfactin. In tandem MS spectra of ions at m/z1044.642 and 1058.701,
231
similar fragmentation patterns were observed (Fig. 4). There were no mass shifts in the
232
second series fragments, but mass shift of 14/28 Da were found in the first series of product
233
ions (931.57/945.58, 818.48/832.50, 703.45/717.45 and 604.39/618.39), suggesting that these
234
two compounds had additional one or two CH2 in fatty acid residues. Therefore, compounds
235
in fraction 2, 3 and 4 were identified as C13, C14 and C15 surfactins, respectively.
236
3.4 Identification of plipastatin
N-terminal
amino
acids
(FA-Glu,
FA-Glu-Leu,
FA-Glu-Leu-Leu,
EP
TE D
M AN U
SC
and
RI PT
224
Some Bacillus strains are known to secrete antifungal agents. Fengycin, which is active
238
against Rhizopus, is produced by B. subtilis (Ongena, et al., 2005). It has been reported that
239
fengycin and plipastatin are different in one amino acid residue; Glu in fengycin is substituted
240
with Gln in plipastatin (Tsuge, Ano, Hirai, Nakamura, & Shoda, 1999). The culture
241
supernatant of OSY-7LA was analyzed by LC/MS/MS for a quick characterization of any
242
antifungal agents. Two doubly protonated ions at m/z 739.4140 and 739.4137, with different
243
retention times, were found in agreement with fengycin mass (Chen, Wang, Wang, Hu, &
244
Wang, 2010). Tandem MS was performed on these two ions to obtain structural information.
AC C
237
13
ACCEPTED MANUSCRIPT For molecular ion at m/z 739.4140, the set of product ions (1364.65, 1201.63, 976.04, 905.40,
246
675.41, 512.22 and 398.08) suggest losing of Ile, Tyr, Gln-Pro, Ala, Glu-Thr, Tyr and Orn
247
sequentially from C-terminal of parent ion (Fig. 5a). As there was one Gln, this compound
248
was consistent with plipastatin A. For molecular ion at m/z 739.4137, similar daughter ions
249
(1364.57, 1201.53 and 976.15) and ions with mass shift of 28 Da (877.32, 647.38, 484.15 and
250
370.02) were observed (Fig. 5b). Nevertheless, compared to plipastatin A, the fifth position
251
amino acid (Ala) from C-terminal was substituted by Val, suggesting that this compound was
252
plipastatin B. Therefore, in addition to subtilosin and surfactin, the new isolate OSY-7LA
253
also is producing the antifungal lipopeptides, plipastatin A and plipastatin B.
254
3.5 Inhibition of Listeria in Vienna sausage by crude extract from OSY-7LA
M AN U
SC
RI PT
245
The presence of crude extract (125 AU/sausage) in Vienna sausage which was inoculated
256
with Listeria showed significant (P<0.05) inhibitory effect (Fig. 6). After 12 or 24 h
257
incubation, the crude extract group achieved 2-log reduction compared to control group.
258
4. Discussion
EP
TE D
255
A new bacterial strain, OSY-7LA, was isolated by screening food samples for
260
microorganisms producing potent antimicrobial metabolites. The isolate was identified as B.
261
atrophaeus by a combination of morphological, biochemical and genetic analyses. This strain
262
showed good activity against Gram-positive bacteria (e.g., L. monocytogenes and
263
methicillin-resistant S. aureus) and a fungus (i.e., R. arrhizus).Relevant antimicrobial agents
264
were characterized by different mass spectrometry techniques.
AC C
259
14
ACCEPTED MANUSCRIPT The species, B. atrophaeus, was first proposed by Nakamura (1989) after DNA-DNA
266
reassociation measurements, multilocus enzyme electrophoresis and pigment examination. It
267
is difficult to distinguish B.atrophaeus from B.subtilis by conventional tests except the black
268
pigment production (Burke, Wright, Robinson, Bronk, & Warren, 2004). In the present study,
269
strain OSY-7LA and B. subtilis were indistinguishable using biochemical tests, carbohydrates
270
fermentation or 16S rDNA relatedness. However, black pigment production on tryptose agar
271
was an indication that the strain belongs to B. atrophaeus.
SC
RI PT
265
The cultural supernatant of OSY-7LA showed good activity against several foodborne
273
pathogens and the methicillin-resistant S. aureus, suggesting the potential use of the strain in
274
food or clinical applications. The antimicrobials were subsequently identified as subtilosin,
275
surfactin and plipastatin. Subtilosin was firstly isolated from B. subtilis168 and had been
276
reported to be produced by B. atrophaeus strains (Babasaki, Takao, Shimonishi, & Kurahashi,
277
1985; Stein, et al., 2004). Surfactin and plipastatin are non-ribosomally synthesized
278
lipopeptides that are produced by Bacillus isolates (Tsuge, Ano, & Shoda, 1996). Some
279
bacterial strains have been reported to coproduce different antimicrobial peptides
280
(Arguelles-Arias, et al., 2009; Kim, Ryu, Kim, & Chi, 2010; Roongsawang, et al., 2002).
281
However, no microorganism was found to co-produces these three antimicrobial agents
282
simultaneously. It has been reported that food ecosystems influence the efficacy of
283
bacteriocin (Galvez, et al., 2007). Subtilosin was employed to antagonize Listeria strain in
284
Vienna sausage in the current study. Significant inhibitory effect was observed after 12 and
285
24 h incubation, suggesting that this bacteriocin is practically useful in food preservation.
AC C
EP
TE D
M AN U
272
15
ACCEPTED MANUSCRIPT 286
5. Conclusion, A new bacterial strain, designated OSY-7LA, was isolated from food and identified as B.
288
atrophaeus. The isolate was active against foodborne pathogens and antibiotic resistant strain
289
(methicillin-resistant S. aureus). Bacterioin produced by this strain showed significant
290
inhibitory effect against Listeria strain in Vienna sausage and is potentially useful to combat
291
pathogens in food industry.
292
Acknowledgements
M AN U
SC
RI PT
287
This research is supported by an endowment from Ginni and Frank Bazler and a
294
scholarship to Y. Guo from the Chinese Government. We thank B. Kemmenoe (OSU
295
Campus Microscopy and Imaging Facility) for assistance with SEM examination.
AC C
EP
TE D
293
16
ACCEPTED MANUSCRIPT References
AC C
EP
TE D
M AN U
SC
RI PT
Amrouche, T., Sutyak Noll, K., Wang, Y., Huang, Q., & Chikindas, M. (2010). Antibacterial Activity of Subtilosin Alone and Combined with Curcumin, Poly-Lysine and Zinc Lactate Against Listeria monocytogenes Strains. Probiotics and Antimicrobial Proteins, 2(4), 250-257. Arguelles-Arias, A., Ongena, M., Halimi, B., Lara, Y., Brans, A., Joris, B., & Fickers, P. (2009). Bacillus amyloliquefaciens GA1 as a source of potent antibiotics and other secondary metabolites for biocontrol of plant pathogens. Microb Cell Fact, 8, 63. Babasaki, K., Takao, T., Shimonishi, Y., & Kurahashi, K. (1985). Subtilosin A, a new antibiotic peptide produced by Bacillus subtilis 168: isolation, structural analysis, and biogenesis. J Biochem, 98(3), 585-603. Burke, S. A., Wright, J. D., Robinson, M. K., Bronk, B. V., & Warren, R. L. (2004). Detection of molecular diversity in Bacillus atrophaeus by amplified fragment length polymorphism analysis. Appl Environ Microbiol, 70(5), 2786-2790. Chen, L., Wang, N., Wang, X., Hu, J., & Wang, S. (2010). Characterization of two anti-fungal lipopeptides produced by Bacillus amyloliquefaciens SH-B10. Bioresour Technol, 101(22), 8822-8827. Crandall, A. D., & Montville, T. J. (1998). Nisin resistance in Listeria monocytogenes ATCC 700302 is a complex phenotype. Appl Environ Microbiol, 64(1), 231-237. Floriano, B., Ruiz-Barba, J. L., & Jimenez-Diaz, R. (1998). Purification and genetic characterization of enterocin I from Enterococcus faecium 6T1a, a novel antilisterial plasmid-encoded bacteriocin which does not belong to the pediocin family of bacteriocins. Appl Environ Microbiol, 64(12), 4883-4890. Fujita, K., Ichimasa, S., Zendo, T., Koga, S., Yoneyama, F., Nakayama, J., & Sonomoto, K. (2007). Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria. Appl Environ Microbiol, 73(9), 2871-2877. Galvez, A., Abriouel, H., Lopez, R. L., & Ben Omar, N. (2007). Bacteriocin-based strategies for food biopreservation. Int J Food Microbiol, 120(1-2), 51-70. Gao, K. (1998). Chinese studies on the edible blue-green alga, Nostoc flagelliforme: a review. Journal of Applied Phycology, 10(1), 37-49. Guinane, C. M., Cotter, P. D., Hill, C., & Ross, R. P. (2005). Microbial solutions to microbial problems; lactococcal bacteriocins for the control of undesirable biota in food. J Appl Microbiol, 98(6), 1316-1325. Guo, Y., Huang, E., Yuan, C., Zhang, L., & Yousef, A. E. (2012). Isolation of a Paenibacillus sp. strain and structural elucidation of its broad-spectrum lipopeptide antibiotic. Appl Environ Microbiol, 78(9), 3156-3165. He, Z., Kisla, D., Zhang, L., Yuan, C., Green-Church, K. B., & Yousef, A. E. (2007). Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin. Appl Environ Microbiol, 73(1), 168-178. 17
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
Huang, T., Geng, H., Miyyapuram, V. R., Sit, C. S., Vederas, J. C., & Nakano, M. M. (2009). Isolation of a variant of subtilosin A with hemolytic activity. J Bacteriol, 191(18), 5690-5696. Jack, R. W., Tagg, J. R., & Ray, B. (1995). Bacteriocins of gram-positive bacteria. Microbiol Rev, 59(2), 171-200. Kaletunc, G., Lee, J., Alpas, H., & Bozoglu, F. (2004). Evaluation of structural changes induced by high hydrostatic pressure in Leuconostoc mesenteroides. Appl Environ Microbiol, 70(2), 1116-1122. Kawulka, K. E., Sprules, T., Diaper, C. M., Whittal, R. M., McKay, R. T., Mercier, P., Zuber, P., & Vederas, J. C. (2004). Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives. Biochemistry, 43(12), 3385-3395. Kim, P. I., Ryu, J., Kim, Y. H., & Chi, Y. T. (2010). Production of biosurfactant lipopeptides Iturin A, fengycin and surfactin A from Bacillus subtilis CMB32 for control of Colletotrichum gloeosporioides. J Microbiol Biotechnol, 20(1), 138-145. McCormick, J. K., Poon, A., Sailer, M., Gao, Y., Roy, K. L., McMullen, L. M., Vederas, J. C., Stiles, M. E., & Van Belkum, M. J. (1998). Genetic characterization and heterologous expression of brochocin-C, an antibotulinal, two-peptide bacteriocin produced by Brochothrix campestris ATCC 43754. Appl Environ Microbiol, 64(12), 4757-4766. Nakamura, L. K. (1989). Taxonomic Relationship of Black-Pigmented Bacillus subtilis Strains and a Proposal for Bacillus atrophaeus sp. nov. Int. J. Syst. Bacteriol., 39, 295-300. Ongena, M., Jacques, P., Toure, Y., Destain, J., Jabrane, A., & Thonart, P. (2005). Involvement of fengycin-type lipopeptides in the multifaceted biocontrol potential of Bacillus subtilis. Appl Microbiol Biotechnol, 69(1), 29-38. Pecci, Y., Rivardo, F., Martinotti, M. G., & Allegrone, G. (2010). LC/ESI-MS/MS characterisation of lipopeptide biosurfactants produced by the Bacillus licheniformis V9T14 strain. J Mass Spectrom, 45(7), 772-778. Perez, R. H., Zendo, T., & Sonomoto, K. (2014). Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications. Microb Cell Fact, 13 Suppl 1, S3. Reunanen, J., & Saris, P. E. (2003). Microplate bioassay for nisin in foods, based on nisin-induced green fluorescent protein fluorescence. Appl Environ Microbiol, 69(7), 4214-4218. Roongsawang, N., Thaniyavarn, J., Thaniyavarn, S., Kameyama, T., Haruki, M., Imanaka, T., Morikawa, M., & Kanaya, S. (2002). Isolation and characterization of a halotolerant Bacillus subtilis BBK-1 which produces three kinds of lipopeptides: bacillomycin L, plipastatin, and surfactin. Extremophiles, 6(6), 499-506. Ross, R. P., Morgan, S., & Hill, C. (2002). Preservation and fermentation: past, present and future. Int J Food Microbiol, 79(1-2), 3-16.
18
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
Shelburne, C. E., An, F. Y., Dholpe, V., Ramamoorthy, A., Lopatin, D. E., & Lantz, M. S. (2007). The spectrum of antimicrobial activity of the bacteriocin subtilosin A. J Antimicrob Chemother, 59(2), 297-300. Stein, T., Dusterhus, S., Stroh, A., & Entian, K. D. (2004). Subtilosin production by two Bacillus subtilis subspecies and variance of the sbo-alb cluster. Appl Environ Microbiol, 70(4), 2349-2353. Sutyak, K. E., Wirawan, R. E., Aroutcheva, A. A., & Chikindas, M. L. (2008). Isolation of the Bacillus subtilis antimicrobial peptide subtilosin from the dairy product-derived Bacillus amyloliquefaciens. J Appl Microbiol, 104(4), 1067-1074. Tsuge, K., Ano, T., Hirai, M., Nakamura, Y., & Shoda, M. (1999). The genes degQ, pps, and lpa-8 (sfp) are responsible for conversion of Bacillus subtilis 168 to plipastatin production. Antimicrob Agents Chemother, 43(9), 2183-2192. Tsuge, K., Ano, T., & Shoda, M. (1996). Isolation of a gene essential for biosynthesis of the lipopeptide antibiotics plipastatin B1 and surfactin in Bacillus subtilis YB8. Arch Microbiol, 165(4), 243-251. Weisburg, W. G., Barns, S. M., Pelletier, D. A., & Lane, D. J. (1991). 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol, 173(2), 697-703. Woraprayote, W., Kingcha, Y., Amonphanpokin, P., Kruenate, J., Zendo, T., Sonomoto, K., Benjakul, S., & Visessanguan, W. (2013). Anti-listeria activity of poly(lactic acid)/sawdust particle biocomposite film impregnated with pediocin PA-1/AcH and its use in raw sliced pork. Int J Food Microbiol, 167(2), 229-235. Zheng, G., Yan, L. Z., Vederas, J. C., & Zuber, P. (1999). Genes of the sbo-alb locus of Bacillus subtilis are required for production of the antilisterial bacteriocin subtilosin. J Bacteriol, 181(23), 7346-7355.
19
ACCEPTED MANUSCRIPT Table 1 Antimicrobial spectrum of OSY-7LA cultural supernatant. Media
Activity
Gram-positive bacteria Bacillus cereus ATCC 14579 B. cereus ATCC 11778 Enterococcus faecalis Listeria innocua ATCC 33090 L. monocytogenes Scott A Staphylococcus aureus ATCC 6538 S. aureus (methicillin-resistant)
TSBYE TSBYE TSBYE TSBYE TSBYE TSBYE TSBYE
+++ +++ ++ +++ +++ ++ ++
Gram-negative bacteria Escherichia coli K-12 E. coli O157:H7 EDL 933 Salmonella enterica serovar Typhimurium Yesinia enterocolitica
LB LB TSBYE TSBYE
-
Fungus Rhizopus arrhizus
APCA
++
M AN U
SC
RI PT
Strains*
safety
TE D
*Strains obtained from the culture collection of The Ohio State University food
laboratory. TSBYE, Tryptic soy broth supplemented with 0.6% yeast extract; LB,
EP
Luria–Bertani medium; APCA, plate count agar containing chlortetracycline hydrochloride and chloramphenicol. +++, inhibitory zone diameter > 20 mm; ++, inhibitory zone diameter
AC C
between 10 mm and 20 mm; +, inhibitory zone diameter < 10 mm; -, no inhibition.
20
ACCEPTED MANUSCRIPT Fig. 1. Bacillus atrophaeus OSY-7LA cells, as examined by the scanning electron microscope. Fig. 2. High performance liquid chromatography (HPLC) profile of crude extract from
RI PT
Bacillus atrophaeus OSY-7LA cultural supernatant. Four peaks (indicated by arrows) showed antimicrobial activities against Listeria innocua, these correspond to retention
SC
times of 23.06, 29.04, 30.16, and 31.35 min, respectively.
Fig. 3. MALDI-TOF MS examination of antimicrobial agents purified by high performance
M AN U
liquid chromatography (HPLC). (a) fraction 1 with retention time of 23.06 min showed protonated ion at m/z of 3401.414 ; (b) fraction 2 with retention time of 29.04 min showed the sodiated ion at m/z of 1030.553; (c) faction 3 with retention time of 30.16 min showed the sodiated ion at m/z of 1044.642; (d) fraction 4 with retention
numbers).
TE D
time of 31.35 min showed the sodiated ion at m/z of 1058.701 (See Fig. 2 for fraction
EP
Fig. 4. MS/MS analyses of surfactin homologues from fraction 2 (sodiated ion at m/z
AC C
1030.64), 3 (sodiated ion at m/z 1044.67) and 4 (sodiated ion at m/z 1058.69). Fig. 5. MS spectra of plipastatin A and B which corresponded to two doubly protonated ions at m/z 739.4140 and 739.4137 as analyzed by LC/MS/MS. (a) plipastatin A; (b) plipastatin.
Fig. 6. Inhibition of Listeria innocua in Vienna sausage by OSY-7LA crude extract. Asterisk symbol (*) in the figure indicates a statistically significance between the treatment and the control. Average results from three replicates on tryptic soy agar. 21
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT A new Bacillus atrophaeus strain was isolated and identified The strain was found to produce multiple antimicrobial agents The structures of antimicrobials were confirmed by mass spectrometry and PCR
AC C
EP
TE D
M AN U
SC
RI PT
The antimicrobials resulted in 2-log reduction of Listeria in a model food